Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fresh Chances for Advocates

Sherine Gabriel, MD  |  Issue: February 2009  |  February 1, 2009

Advocacy is the pursuit of influencing outcomes—including public policy and resource allocation decisions within political, economic, and social systems and institutions—that directly affect people’s lives.

—David Cohen, Advocacy for Social Justice, 2001

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

One of the main responsibilities of a professional organization is advocacy on behalf of its members. This is a responsibility the ACR takes seriously. There has been a concerted effort over the past few years to ramp up our advocacy activities. In that time period, we have expanded our Advocates for Arthritis advocacy day, increased our presence on Capitol Hill, started RheumPAC—the ACR’s Political Action Committee, and increased efforts on keeping members informed of legislative issues that will affect rheumatology. There has also been an added emphasis on providing new ways for members to get involved in advocacy efforts. With a new American president comes a new opportunity for the ACR to advocate for issues of importance to the rheumatology community.

When Barack Obama won the presidential election on Tuesday, November 4, 2008, he stated, “The road ahead will be long. Our climb will be steep. We may not get there in one year or even in one term.” President Obama was talking about change in the United States. I like to think that he was referring, at least in part, to change in our healthcare system. The promise of healthcare reform is a large part of the 111th Congress and an important goal for the new administration. As the professional association charged with protecting the interests of rheumatologists, the ACR must seize the opportunity to play an instrumental role in determining the direction of healthcare reform, particularly for chronic diseases in this country.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Obama’s Plans for Healthcare Reform

Healthcare reform was a hot topic during the recent presidential election. Each candidate had his or her own plan as to what healthcare reform would mean for the United States and the role that his or her respective administration would play in making their change a reality. For example, one of President Obama’s key initiatives during his campaign was healthcare for children. The State Children’s Health Insurance Program (SCHIP) is a program that is continuously running out of funds on the state level and will expire on March 31, 2009. President Obama’s plan is to expand the program to encompass more children for a longer period of time. The ACR is continuously monitoring SCHIP to ensure that pediatric patients with rheumatic diseases have adequate access to the unique expertise of pediatric rheumatologists because we know that such care can make the difference between disability and functionality for these patients.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:CongressHealthcare ReformLegislationObamaPolitics

Related Articles

    The Health Buzz

    November 1, 2009

    What is the ACR doing with healthcare reform?

    In Advocacy, Slow and Steady Wins the Race

    April 1, 2010

    Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

    How Rheumatologists Can Mobilize Patients as Advocates, Activists

    June 15, 2015

    Editor’s note: This is the first installment of a two-part series showing how a busy office-based practice can incorporate patient advocacy into its standard workflow. Part 1 outlines the reasons for advocacy and the benefits to both patients and doctors, then gives a quick-start outline to get you started. Part 2 will amplify the concepts…

    President’s Perspective: ACR Addresses Reform of Sustainable Growth Rate Formula

    December 1, 2013

    The College’s multi-pronged plan to replace flawed SGR payment system requires continued support from rheumatologists, healthcare professionals

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences